Softwr

Research · head to head

Genedata vs REDCap

Genedata logo

Genedata

Research

Enterprise R&D data platforms for biologics, screening and bioprocess, owned by Danaher

From
On request
Rated
-
REDCap logo

REDCap

Research

Research data capture licensed free to non-profits, and not licensable at all to companies

From
On request
Rated
-

The short version

  • Each has a real cost: Genedata there is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.; REDCap a for-profit company cannot hold a licence or self-host REDCap, so a biotech or CRO that liked it at university simply cannot deploy it the same way and must buy a commercially licensed hosted version instead.
  • They diverge on capability: Genedata covers Screener, REDCap covers Form and survey designer.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Genedata and REDCap actually diverge.

Attributes where Genedata and REDCap differ
AttributeGenedataREDCap
PlatformsWeb, On-premise, Private cloudWeb, Linux, Windows

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Genedata

  • Screener
  • Biologics
  • Bioprocess
  • Expressionist
  • Selector
  • Profiler
  • Instrument integration
  • GxP-capable deployments

Only in REDCap

  • Form and survey designer
  • Longitudinal projects
  • Data quality rules
  • Randomisation
  • Audit trail and e-signature
  • API and exports

What people use each for

The jobs each tool is most often brought in to do.

Genedata

  • A pharmaceutical screening group processing thousands of plates a week where manual QC and curve fitting no longer scalenot REDCap
  • A biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheetsnot REDCap
  • A process development group standardising bioprocess run data across sites for modelling and scale-upnot REDCap
  • A CRO delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelinesnot REDCap

REDCap

  • An academic research group at an institution that already runs REDCap, where a new study database costs nothing beyond the time to build itnot Genedata
  • A hospital collecting patient reported outcomes where data must stay on institutional infrastructure rather than a vendor cloudnot Genedata
  • An investigator initiated trial that needs randomisation, an audit trail and statistical export without a commercial EDC budgetnot Genedata
  • A multi site academic collaboration where each site can be given scoped access to a single longitudinal projectnot Genedata

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Genedata

  • There is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
  • Platforms are licensed individually and most organisations need two or three, so the real contract is a sum of separate licences plus the integration work between them.
  • Deployment is a services programme rather than an installation, running months and requiring scientific configuration by the vendor, which means value arrives long after the first invoice.
  • Danaher ownership since 2023 gives the roadmap a natural pull toward Danaher instrument and bioprocessing lines, which is an advantage on that hardware and a question to ask if your instrument estate is from competitors.
  • Validated deployments for regulated use add scope, cost and an ongoing revalidation obligation on your side after each vendor release, and that recurring internal effort is rarely counted in the business case.

REDCap

  • A for-profit company cannot hold a licence or self-host REDCap, so a biotech or CRO that liked it at university simply cannot deploy it the same way and must buy a commercially licensed hosted version instead.
  • Because each institution hosts its own instance, support, uptime, backup and version currency vary by university, and a researcher has no recourse to Vanderbilt when the local instance is two years out of date.
  • It is free of licence fee but not free of cost: the hosting institution carries server, security, patching and support staffing, which is why some institutions charge internal recharges per project.
  • Validation for regulated use is the deploying institution responsibility, so an instance is not Part 11 compliant simply because REDCap supports the features; someone locally has to produce and maintain the evidence.
  • The interface and reporting are dated compared with commercial survey and EDC tools, and complex logic is built through data dictionary spreadsheets rather than a modern visual builder, which slows non technical study teams.

Pricing, plan by plan

Genedata

On request
  • Genedata platform licence$undefined/year
    • Each platform, such as Screener or Biologics, licensed separately
    • Annual enterprise subscription scoped on users, sites and data volume
    • Implementation and scientific configuration services quoted as a separate programme

REDCap

On request
  • REDCap non-profit licence$undefined/year
    • No licence fee to non-profit and government institutions that join the consortium
    • Institution must install and host it on its own infrastructure
    • For-profit organisations may not hold a licence or self-host

Which should you pick?

Choose Genedata if

  • You need screener.
  • You work on Web, On-premise, Private cloud.
  • You also want biologics.

Choose REDCap if

  • You need form and survey designer.
  • You work on Web, Linux, Windows.
  • You also want longitudinal projects.

Questions people ask

Is Genedata or REDCap better?
Neither clearly leads. Genedata starts at On request and REDCap at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Genedata or REDCap?
Genedata starts at On request and REDCap at On request.
Does Genedata or REDCap run on more platforms?
Genedata runs on Web, On-premise, Private cloud. REDCap runs on Web, Linux, Windows.
What is Genedata best used for?
Genedata is most often used for a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale, a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets, a process development group standardising bioprocess run data across sites for modelling and scale-up, a cro delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelines. Of those, a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale and a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets are not what REDCap is typically brought in for.
What can Genedata do that REDCap cannot?
Genedata covers Screener, Biologics, Bioprocess, Expressionist. REDCap covers Form and survey designer, Longitudinal projects, Data quality rules, Randomisation.

Answered from the vendors’ own pages

Genedata: Who owns Genedata?

Danaher acquired the company in 2023. It remains headquartered in Basel and continues under the Genedata name.

REDCap: Is REDCap really free?

The licence is free to non-profit institutions and government organisations that join the consortium, but they must host and support it themselves, so there is real internal cost.

Genedata: Is there a small-team or starter option?

No. Everything is an enterprise contract scoped by users, sites and data volume, with services attached.

REDCap: Can my company use REDCap?

Not by holding a licence or self-hosting. For-profit organisations must use a separately licensed commercial hosted route.

Genedata: Do I buy one product or the whole suite?

Each platform is licensed separately. Most customers license two or three and integrate between them.

REDCap: Is REDCap 21 CFR Part 11 compliant?

It has the features to support Part 11 use, but compliance depends on how the hosting institution configures, validates and documents its own instance.

Genedata: Can it be used in a GxP environment?

Yes, with a validated deployment contracted as additional scope. Ongoing revalidation after releases remains your responsibility.

REDCap: Who supports it?

Your local institutional REDCap administrator, not Vanderbilt. Support quality varies by site.

Share

Related pages

Other head to heads